findmyKOL

Mark Milton, MD

Basic profile

St. John Medical Center

ORCIDNone on fileNPI
RegionCedar Rapids, IA · MidwestSpecialtyClinical Cardiac ElectrophysiologyFocusCardiology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2020Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Mark Milton is a Cardiology physician affiliated with St. John Medical Center. OpenAlex indexes 13 publications with 508 citations (h-index 4).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
13publications

Distinct works indexed by OpenAlex.

508citations

Total citations across indexed works.

4h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
17companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

788 8th Avenue SE
Suite 400
Cedar Rapids, IA 52401

Telephone

319-832-2328

Provider last certified this registry record 21 Dec 2021.

View the NPPES registry record

Industry payments

17 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    56.8%
    Beta blocker30.6%
    Metoprolol Succinate66%Metoprolol Tartrate20%Sotalol7%Carvedilol4%Atenolol2%Bisoprolol Fumarate1%
    Part D<11 patients
    Antiarrhythmic10.2%
    Amiodarone Hcl68%Flecainide Acetate27%Dofetilide3%Mexiletine Hcl3%
    Part D<11 patients

    + 8 more classes in this area

  • Blood & clotting

    38.2%
    Factor Xa inhibitor31.1%
    Eliquis68%Xarelto32%
    Part D213 patients
    Vitamin K antagonist5%
    Warfarin Sodium100%
    Part D56 patients

    + 2 more classes in this area

  • Metabolism & gastrointestinal

    2.6%
    Potassium supplement2%
    Potassium Chloride100%
    Part D32 patients
    Proton pump inhibitor0.6%
    Pantoprazole Sodium63%Omeprazole37%
    Part D<11 patients
Where care is delivered (Part B)7.3% facility · 92.7% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”